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Glomerular prostaglandin production in diabetic rats with renovascu-
lar hypertension. A rat model combining two-kidney, one-clip (2KIC)
renovascular hypertension and streptozotocin-induced diabetes mclii-
tus was used to assess the pathogenetic significance of vasodilator
prostaglandins in diabetic glomerular injury. Glomeruli isolated from
normotensive diabetic rats produced greater than normal amounts of
PGE2 and 6-keto PGF1,,, under in vitro incubation conditions. In 2KIC
hypertensive-diabetic rats, glomeruli from unclipped kidneys (which
are prone to accelerated diabetic glomerular injury) produced similarly
elevated amounts of PGE2 and 6-keto PGF1,, which significantly
exceeded the levels produced by glomeruli from clipped kidneys (which
are relatively protected from glomerular injury), despite exposure to a
similar diabetic environment. In contrast, glomeruli from both Un-
clipped and clipped kidneys of 2KIC hypertensive-non-diabetic rats
produced normal amounts of PGE2 and 6-keto PGF1. These results
suggests a correlation between vasodilator prostaglandin metabolism
and susceptibility to diabetic glomerular injury, and illustrate that
enhanced glomerular prostaglandin production is not an invariable
metabolic consequence of hyperglycemia or insulin deficiency. The
data also demonstrate that hemodynamic as well as metabolic factors
may influence glomerular prostaglandin metabolism in experimental
diabetes mellitus.
Glomerular hemodynamic abnormalities are prominent in the
early stages of human [1—3] and experimental [4—61 diabetes
mellitus, and may play a pathogenetic role in the initiation and
progression of diabetic glomerular injury [7—81. Production of
vasodilator prostaglandins (PGE2, PGI2) by isolated glomeruli is
enhanced in early diabetes [9—111. Since diabetic hyperfiltration
can be reversed by cyclooxygenase inhibition [11—141 and by
insulin treatment [1, 11, 151, both of which normalize glomeru-
lar prostaglandin production [9, 11], a role for prostaglandins in
the mediation of early diabetic hyperfiltration has been pro-
posed [9, 11, 13, 141. However, other preliminary studies
suggest that enhanced glomerular prostaglandin production
may not be directly relevant to disturbances in glomerular
hemodynamics in experimental diabetes [16, 17].
In order to address this question, we studied glomerular
prostaglandin metabolism in a rat model combining streptozo-
tocin-induced diabetes mellitus and unilateral renovascular
hypertension. Unclipped kidneys of two-kidney, one-clip (2KIC)
hypertensive rats develop hyperfiltration and intraglomerular
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hypertension [18—20] similar to diabetic kidneys, yet diabetic-
like glomerular injury does not occur [21]. Unlike diabetic
kidneys, unclipped kidneys of 2K1C hypertensive rats produce
decreased amounts of vasodilator glomerular prostaglandins
compared to normals [22] and have increased levels of pre-
giomerular vascular resistance [6, 20], factors which may pro-
tect the glomerular capillary bed from injury. However, when
2KIC hypertensive rats are made diabetic, unclipped kidneys
develop diabetic glomerular injury exceeding that of normoten-
sive diabetic rats [211, while clipped kidneys are relatively
protected from diabetic damage [21], Since the unclipped and
clipped kidneys of 2K1C hypertensive-diabetic rats are both
exposed to a diabetic environment, but have dissimilar hemo-
dynamic profiles and susceptibility to diabetic glomerular dam-
age, this preparation could provide insight into the importance
of vasodilator prostaglandins in diabetic hemodynamic renal
injury. Consequently, we compared the production of glomer-
ular vasodilator prostaglandins from unclipped and clipped
kidneys of 2KIC hypertensive-diabetic rats with that of hyper-
tensive, diabetic and normal controls.
Methods
Animal preparation
Male Sprague-Dawley rats weighing ISO to 180 grams (Taconic
Farms, Germantown, New York. USA) maintained on standard
chow (Purina Formulab #5008, 23.5% protein, Ralston Purina,
St. Louis, Missouri, USA) and water ad libitum were divided
into four experimental groups: normal, diabetic, hypertensive,
and hypertensive-diabetic. Under ether anesthesia, 2KIC hy-
pertension was induced in hypertensive and hypertensive-
diabetic rats by placement of a solid silver clip (slit width 0.22
mm) on the origin of the left renal artery (week 0). The right
kidney was not disturbed, After three weeks, systolic blood
pressure of rats in all four groups was determined by tail
plethysmography under light ether anesthesia using a photo-
electric pulse sensor (Grass Instruments, Quincy, Massachu-
setts, USA) and a 20 x 12 mm tubular occluding cuff (NARCO-
Biosystems, Houston, Texas, USA) connected to a pressure
transducer (Statham P23DC, Hato Ray, Puerto Rico) and
displayed on a Grass physiograph. The mean of six determina-
tions over two to three minutes was taken as systolic pressure.
Only rats with systolic blood pressure over 150 mm Hg were
included in the hypertensive groups.
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Following blood pressure measurement on week 3, for the
diabetic and hypertensive-diabetic groups, diabetes mellitus
was induced by injection of streptozotocin (Upjohn Company,
Kalamazoo, Michigan, USA) 60 mg/kg, into a tail vein. The
normal and hypertensive groups received injections of the
vehicle (0.11 M citrate buffer, ph 4.0) alone.
One week after injection of streptozotocin or buffer (week 4),
systolic blood pressure and non-fasting blood samples for
determination of plasma glucose were obtained from each
group. Only rats with plasma glucose greater than 350 mg/dl,
systolic blood pressure greater than 150 mm Hg, or both of
these, were included in the diabetic, hypertensive, and hyper-
tensive-diabetic groups, respectively. Additional blood samples
were obtained via aortic puncture from each animal at sacrifice
(week 5).
Preparation of isolated glomeruli
Glomeruli were isolated by a modification of the technique
described by Sraer Ct al [23], 27 to 41 days (mean 36 days) after
renal artery clipping in hypertensive and hypertensive-diabetic
rats and 11 to 21 days (mean 15 days) after streptozotocin or
buffer injection in all groups. Under ether anesthesia, a poly-
ethylene catheter was placed in the infra-renal aorta, the
supra-renal aorta was clamped and the kidneys were perfused
by syringe pump with ice-cold heparinized isotonic saline
solution (20 to 40 ml over about 2 minutes) until blanched. The
kidneys were removed, stripped of capsular tissue, weighed and
the renal cortex was dissected free. Normal and diabetic rats
were sacrificed individually with renal cortical tissue from right
and left kidneys pooled for glomerular isolation. Hypertensive
and hypertensive-diabetic rats were sacrificed in pairs; pooled
cortical tissue from clipped and unclipped kidneys was proc-
essed separately but simultaneously.
The renal cortex was minced to a fine paste, thinned with
ice-cold 20 mtvi TRIS buffer (ph 7.4 at 5°C, containing 135 mM
NaC1, 10 mrs KCI, 10 m sodium acetate, 5 mM glucose) and
passed through a 106 M sieve (which excludes tubules and
vessels and passes glomeruli) with gentle agitation. The result-
ing suspension was poured onto a 75 M sieve (which retains
glomeruli) and washed with cold buffer. Glomeruli were col-
lected off of the 75 M sieve, resuspended in buffer, and
centrifuged at 120 x g for three minutes. The supernatant was
discarded, the resuspended glomeruli were passed through a 25
gauge needle, centrifuged and washed twice. The final prepara-
tion consists of glomeruli, decapsulated and largely free of
arteriolar segments. Tubular fragments, monitored by light
microscopy, make up less than 10% of the preparation.
For measurement of prostaglandin production, glomeruli
were resuspended in 1.0 ml of TRIS buffer (ph 7.40 at 37°C)
containing 1.0 mivi CaCI2 and incubated in a shaking water bath
at 37°C for thirty minutes. Following incubation, glomerular
suspensions were immediately cooled, centrifuged at 1000 x g
for four minutes, and the supernatant was separated and frozen
for radioimmunoassay. Protein content of each glomerular
pellet was determined by the Lowry method [241 and averaged
0.9 to 1.75 mg per incubation.
At sacrifice the thoracic aorta was removed, placed into
ice-cold Tris buffer without CaCl2, dissected free of connective
tissue, and divided into rings weighing 3 to 5 mg. Aortic rings
were incubated in triplicate in 0.2 ml of Tris buffer containing
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Fig. 1. Growth of nor,nal (•, N = II), diabetic (0, N = II), hvper-
tensive (A, N = 27) and hypertensive-diabetic (A N = 28) rats.
Hypertensive and hypertensive-diabetic animals underwent renal artery
clipping at week 0. Diabetic and hypertensive-diabetic rats received
streptozotocin at week 3, normal and hypertensive rats received citrate
buffer only at week 3. All groups were sacrificed at week 5 (Methods).
Data expressed as mean 5EM.
1.0 mM CaCI2 without (basal) or with (stimulated) added ara-
chidonic acid (30 LM) in a shaking water bath at 37°C for twelve
minutes. Following incubation, aortic rings were removed,
weighed, and the supernatant buffer frozen for radioimmunoas-
say.
Assays
Plasma creatinine was determined by a modified Jaffe reac-
tion [251, and plasma glucose by the glucose oxidase method
[261.
Measurements of PGE2, 6-keto PGF1, (the stable degradation
product of PG!2 or prostacyclin) and thromboxane (Tx)B2 (the
stable degradation product of TxA2) were carried out by direct
radioimmunoassay of glomerular and aortic incubation super-
natants without further purification. H3 labeled prostaglandins
were purchased from New England Nuclear (Boston, Massa-
chusetts, USA) or Amersham Co. (Arlington Heights, Illinois,
USA). Prostaglandin antisera were purchased from Seragen
Co., Boston, Massachusetts, USA (TxB2) or prepared in our
laboratory (PGE2, 6-keto PGF1,). Prostaglandin standards were
purchased from Seragen Co.
Unknowns or standards were incubated in duplicate in 1.0 ml
total volume of phosphate buffered saline (ph 7.4) with 0.1%
bovine gamma globulin, H3 labeled prostaglandin, and prosta-
glandin antiserum. Approximately 1.3 x l0 cpm of label was
added to each tube. The antiserum dilution was sufficient to
bind 50% of the label in the absence of added prostaglandin.
Incubations were done overnight at 4°C, Free and bound
prostaglandins were separated by adding 1.0 ml of 40% poly-
ethylene glycol (MW 8000), vortexing while cold and centrifug-
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Table 1. Characteristics of normal, diabetic, hypertensive and hypertensive-diabetic groups
Normal
(N II)
Diabetic Hypertensive
P value
vs.
(N = 27) normal
Hypertensive-diabetic
(N 11)
P value
vs.
normal (N = 28)
P value
vs.
hypertensive
P value
vs.
diabetic
Plasma glucose
mgldl
Systolic blood pressure
mm Hg
Plasma creatinine
rng!dI
177 10
131 3
0.39 0.01
542
136
0.44
18
2
0.03
<0.001
NS
NS
162
181
0.49
5
3
0.03
NS
<0.001
<0.02
503 15
181 4
0.46 0.02
<0.001
NS
NS
NS
<0.001
NS
Plasma glucose (non-fasting) and systolic blood pressure were measured at week 4, seven days following injection of streptozotocin or citrate
buffer. Diabetic and hypertensive-diabetic animals with plasma glucose below 350 mg/dl and hypertensive and hypertensive-diabetic animals with
systolic blood pressure below 150 mm Hg were excluded from the study. Plasma creatinine was measured at sacrifice (week 5).
Table 2. Kidney weight and kidney/body weight ratios
Kidney weight!
Single kidney weight body weight
Group Kidney N grains %
Normal ' 20 1.43 0.04 0.41 0.01
Diabetic a 22 1.66 0.06" 0.61 0.02"
Hypertensive
Hypertensive-diabetic
Right (unclipped)
Left (clipped)
Right (unclipped)
Left (clipped)
26
26
27
27
1.62 0.06"
P < 0.00l
1.16 0.04"
1.96 0.06'
i < o.oo
1.40 0.03'
0.46 0.02"
P < 0.00l
0.33 0,01b
0.67 0.02'
P < O.ooIa
0.48
a Values for right and left kidneys of normal and diabetic rats were similar and data was pooled for these groups
"P < 0.02 vs. normal
P < 0.001 vs. hypertensive unclipped, P < 0.05 vs. diabetic
' P < 0.001 vs. hypertensive clipped and diabetic
P values for right unctipped vs. left clipped kidneys
ing at 2000 x g for 20 minutes. The supernatant was discarded
and the precipitate dissolved in 0.8 ml of I N NaOH. This
solution was poured into 5 ml of scintillation fluid and counted
for 10 minutes. Results were calculated by interpolation from a
weighted parabolic regression of logit (bound/bound at zero
prostaglandin concentration) of the standards versus log dose.
Cross-reactivity of 6-keto PGF1, and PGE2 in each others assay
was <1%, and of either in the TxB2 assay was <0,1%. Glomer-
ular prostaglandin production was expressed in pg/mg glomer-
ular protein/30 mm incubation. Aortic prostaglandin production
was expressed in pg/mg wet aortic tissue/12 mm incubation.
Stotistica/ analysis
Comparisons between experimental groups were made using
Student's t-test for unpaired data. Comparisons between Un-
clipped and clipped kidneys within the hypertensive and hyper-
tensive-diabetic groups were made using Student's t-test for
paired data. Data are expressed as mean SEM.
Results
Normal, diabetic, hypertensive, and hypertensive-diabetic
rats gained body weight at similar rates from week 0 (renal
artery clipping of hypertensive and hypertensive-diabetic groups)
to week 3 (streptozotocin or buffer injection), as shown in
Figure 1. Following induction of diabetes mellitus, diabetic and
hypertensive-diabetic rats lost weight while normal and hyper-
tensive rats continued to gain weight.
Table I compares several characteristics of the four experi-
mental groups. Non-fasting plasma glucose levels of diabetic
and hypertensive-diabetic rats were comparable (542 18 and
503 15 mg/dl, respectively) and significantly higher than that
of normal (177 10 mg/dl) and hypertensive (162 5 mg/dl)
rats. Systolic blood pressure of hypertensive and hypertensive-
diabetic rats on week 4 were comparable (181 3 and 181 4
mm Hg, respectively), and significantly higher than that of
normal (131 3 mm Hg) and diabetic (136 2 mm Hg) rats.
Hypertensive and hypertensive-diabetic rats had plasma creat-
mine levels at sacrifice slightly, but significantly higher than
normal rats, while diabetics were comparable to normal.
The weight of diabetic kidneys exceeded normal kidneys in
absolute terms, and as a per cent of body weight (Table 2),
consistent with previously reported data [27]. Hypertensive
unclipped (H-UNCL) kidneys were significantly larger than
normal kidneys while hypertensive clipped (H-CL) kidneys
were smaller than normal. Similarly, hypertensive-diabetic Un-
clipped (HD-UNCL) kidneys weighed more, and hypertensive-
diabetic clipped (HD-CL) kidneys weighed less than diabetic
kidneys. Despite the size differences created by renal artery
clipping, superimposed diabetes resulted in significant enlarge-
ment of both unclipped and clipped hypertensive-diabetic kid-
neys in comparison to their respective hypertensive counter-
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Table 3. Glomerular production of PGE2, 6-keto PGFI and TxB2a
Group Kidney N PGE2
P value
vs.
diabetic
6-keto
PGFI
P value
vs.
diabetic TxB2
P value
vs.
diabetic
Normal b 10 2360 160 <0.005 1230 100 <0.05 560 80 NS
Diabetic b
Right unclipped
10
14
3980 410
2470 330
—
<0.01
1890 280
1180 130
—
<0.05
950 210
340 40
—
<0.005
Hypertensive
Left clipped
Right unclipped
12
14
NSC
2360 280
4230 490
<0.005
NS
P K 0.05
960 130
1420 150
<0.05
NS
NSC
410 60
530 60
<0.02
NS
Hypertensive-diabetic
Left clipped 13
P < 0.0l
2460 290 <0.005
P K 0.05c
1140 80 <0.01
NS
560 130 NS
a Expressed in pg/mg glomerular pro(ein/30 mm incubation
b Right and left kidneys pooled for glomerular isolation
P value for right unclipped vs. left clipped kidneys
parts. H-UNCL kidneys attained an absolute weight compara-
ble to diabetic kidneys, but were smaller in relation to body
weight (P < 0.02).
Production of PGE2, 6-keto PGF1a and TxB2 by glomeruli
isolated from the four experimental groups is shown in Table 3.
Glomeruli from diabetic rats produced significantly greater
amounts of the vasodilator prostaglandins PGE2 and PGI2
(measured as 6-keto PGF1,) than normals. This finding is in
agreement with previous studies carried out within three weeks
of streptozotocin administration [9—111. There was no correla-
tion between the level of plasma glucose and glomerular PGE2
or 6-keto PGF1a production in diabetic or normal rats. Produc-
tion of the vasoconstrictor TxA2 (measured as TxB2) by dia-
betic glomeruli was also increased from normal, but this differ-
ence did not achieve statistical significance. Others have vari-
ously noted an increase [11] or no change [9] in glomerular TxB2
production early in the course of experimental diabetes. Pro-
duction of PGE2, 6-keto PGF1,. and TxB2 by glomeruli from
clipped and unclipped kidneys of hypertensive rats remained
less than that of diabetic rats in all cases. Although H-UNCL
kidneys produced significantly more glomerular 6-keto PGF1a
than H-CL kidneys, these levels were actually below the mean
values obtained in normal glomeruli.
The superimposition of 2K1C hypertension on streptozo-
tocin-induced diabetes created striking differences in basal
glomerular prostaglandin production (Table 3). Glomeruli from
HD-UNCL kidneys produced PGE2 in amounts which were
significantly greater than normals (P < 0.005) and comparable
to diabetics. In contrast, HD-CL kidneys, which were also
exposed to a diabetic environment, failed to increase glomeru-
lar PGE2 production above normal, remaining at a level signif-
icantly below HD-UNCL and diabetic kidneys. Hypertensive-
diabetic rats exhibited a similar pattern for 6-keto PGF1c.
production. HD-UNCL kidneys produced significantly more
6-keto PGF1a than HD-CL kidneys, approaching the level of
diabetic glomeruli. HD-CL kidneys also failed to increase
glomerular 6-keto PGF1. production above normal and re-
mained significantly less than diabetics. Glomerular TxB2 pro-
duction was not significantly different from normal in hyperten-
sive-diabetic rats.
As an independent assessment of general vascular prosta-
glandin synthesis in each experimental group, basal and arachi-
donic acid stimulated production of 6-keto PGF1 by samples of
thoracic aorta were evaluated (Fig. 2). Aortic tissue from
diabetic and hypertensive-diabetic animals produced less 6-keto
PGF1 than respective non-diabetic animals, however, these
differences were not statistically significant. Added arachidonic
acid stimulated 6-keto PGF1. production in diabetic and hyper-
tensive-diabetic aortas to a greater extent than in normal or
hypertensive aortas.
Discussion
Although alterations in renal prostaglandin metabolism occur
in diabetes mellitus [9—11], the hemodynamic significance of
these changes with respect to the pathogenesis of diabetic renal
disease remains uncertain [9, 11, 16, 171. By combining exper-
imental renovascular hypertension and diabetes mellitus in a
single animal model, it becomes possible to observe the effects
of the diabetic environment on two kidneys with very dissimilar
hemodynamic characteristics [20]. Using this model, Mauer and
co-workers [211 demonstrated that unclipped kidneys of hyper-
tensive-diabetic rats are prone to accelerated diabetic glomer-
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Fig. 2. Basal (shaded bars) and arachidonic acid (30 pM) stimulated
(open bars) 6-keto PGF1a production by aortic rings from normal (N =
11), diabetic only (N = 11), hypertensive (N = 27) and hypertensive-
diabetic (N = 28) rats. * = P < 0.02 vs. corresponding basal value.
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ular damage whereas clipped kidneys are relatively protected,
and then proposed a hemodynamic basis for this differential
susceptibility. We sought to extend these observations by
evaluating prostaglandin production in clipped and unclipped
kidneys of hypertensive-diabetic rats. Glomeruli from HD-
UNCL kidneys produced PGE2 and 6-keto PGF1a in amounts
which were greater than normal and similar to that of normo-
tensive diabetic kidneys. Despite exposure to a diabetic envi-
ronment, however, glomeruli from HD-CL kidneys failed to
increase POE7 and 6-keto PGF1,. production above normal
levels. These results suggest a correlation between vasodilator
prostaglandin metabolism and the susceptibility to diabetic
glomerular injury as described by Mauer [211, and illustrate that
enhanced glomerular prostaglandin production is not an invari-
able metabolic consequence of insulin deficiency.
A number of factors influence in vitro glomerular prostaglan-
din production in experimental diabetes. Metabolic abnormali-
ties associated with the diabetic state clearly have a direct effect
on glomerular prostaglandin metabolism, since euglycemic in-
sulin therapy [9, 11] and addition of insulin to glomerular
incubations in vitro [11] can reduce prostaglandin production to
normal levels. Exposure to hyperglycemic glucose concentra-
tions in vitro, however, does not alter glomerular prostaglandin
production significantly [9, lii. Recently, Craven, Caines and
DeRubertis [11] showed that the duration of untreated experi-
mental diabetes also has an important impact on glomerular
prostaglandin metabolism, Glomeruli isolated from 9 to 15 days
following streptozotocin injection produced increased amounts
of PGE2 and 6-keto PGF, whereas production of these pros-
taglandins was not elevated after four weeks of diabetes.
Previously conflicting studies reporting increased 19, 101 and
normal [28] glomerular prostaglandin production in streptozo-
tocin-induced diabetes mellitus are reconciled by these findings.
In the current study, conducted after a mean of 15 days of
streptozotocin-induced diabetes, enhanced glomerular prosta-
glandin production would therefore be anticipated in the dia-
betic and hypertensive-diabetic groups. Despite these consid-
erations, glomeruli from HD-CL kidneys did not manifest
enhanced prostaglandin production (Table 3).
The possibility of a direct effect of streptozotocin on renal
prostaglandin metabolism is raised by the failure to detect
elevated PGE2 production in the genetically diabetic BB rat
strain [17]. It is conceivable that changes in renal blood flow
created by renal artery clipping could lead to unequal delivery
of streptozotocin to clipped and unclipped kidneys of hyperten-
sive-diabetic rats. Since incubation of normal glomeruli in
streptozotocin-containing media has no effect on PGE2 synthe-
sis [9] and insulin treatment prevents enhanced prostaglandin
production in streptozotocin-treated rats [9, 11], this is an
unlikely explanation for our findings. Despite exposure to a
similar extrarenal diabetic environment, it is also possible that
renal artery clipping produced subtle intrarenal metabolic dif-
ferences between HD-CL and HD-UNCL kidneys, which in
turn influenced prostaglandin metabolism. Therefore, a meta-
bolic contribution to the differential prostaglandin production of
HD-CL and HD-UNCL kidneys cannot be absolutely excluded.
However, the fact that both the clipped and unclipped kidneys
of hypertensive-diabetic rats developed a similar degree of
hypertrophy in response to the induction of diabetes argues
against there being a substantial difference in their metabolic
environment with respect to diabetes.
Since HD-UNCL kidneys were significantly larger than HD-
CL kidneys, the effects of renal hypertrophy per se on glomer-
ular prostaglandin production should be considered. Incuba-
tions from HD-UNCL kidneys contained more glomerular
protein than incubations from HD-CL kidneys (1.75 0.68 mg
and 1.10 0.32 mg, respectively, P < 0.001). Previous studies
indicate that protein content per glomerulus is not altered by
streptozotocin treatment [9] or renal artery clipping [221. There-
fore, it is likely that a larger number of glomeruli were recov-
ered from HD-UNCL than HD-CL kidneys, in agreement with
reported glomerular counts in 2K1C rats [20]. In the present
study, glomerular prostaglandin production is expressed in
relation to glomerular protein content, indicating that true
differences in prostaglandin production per glomerulus exist
between HD-UNCL and HD-CL kidneys.
While increased glomerular production of the vasodilator
prostaglandins PGE2 and PGI2 was apparent in the unclipped
versus the clipped kidneys of hypertensive-diabetic rats, there
were no differences in the production of the vasoconstrictor
TxB2. In addition, TxB2 production did not increase above
normal levels in either of these kidneys. These findings are
significant, since overall vascular tone may be influenced by the
relative production of these vasoactive antagonists. Thus, higher
POE2 and PGI2 production relative to Tx production would
favor net vasodilation in the HD-UNCL kidney more so than in
the HD-CL kidney.
Renal artery clipping alone did not cause significant changes
from normal in glomerular prostaglandin production, although
H-CL kidneys did produce somewhat less 6-keto PGFa than
H-UNCL kidneys. These results differ somewhat than those of
Stahl et al [221, who reported subnormal levels of glomerular
PGE2 and 6-keto PGF1a production by unclipped kidneys of
2KIC rats. Variations in the preparation of 2K1C rats may
account for these differences, since in that study the use of
larger animals and tighter renal artery clips resulting in higher
mean systolic blood pressure levels and lower clipped kidney
weights all suggest a more severe degree of renal artery
stenosis. In any case, 2KIC hypertension per se does not
produce enhanced glomerular vasodilator prostaglandin pro-
duction in the unclipped kidney, as occurs in the hypertensive-
diabetic rat.
Although non-diabetic unclipped kidneys develop elevated
levels of glomerular capillary pressure and blood flow, leading
to hyperfiltration [18—20], diabetic-like glomerular injury does
not occur [21]. Relative protection of the glomerular capillary
bed from more severe hemodynamic injury is provided in this
setting by an increase in afferent vascular resistance [20], which
develops in response to systemic hypertension. While this
autoregulatory mechanism is thought to be largely an intrinsic
property of the renal vasculature [29, 30], it is subject to
alteration by vasoactive substances [31, 321. In contrast to the
non-diabetic unclipped kidney, the diabetic kidney develops
hyperfiltration in association with reduced preglomerular vas-
cular resistance [6]. Vasodilator prostaglandins would be logical
mediators of diabetic hyperfiltration, since their production is
increased in early diabetes and they have a preferential effect on
preglomerular vascular resistance [33]. Thus, the acceleration
of glomerular damage which results from the superimposition of
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diabetes on 2K1C hypertension [21] could be related to in-
creased vasodilator prostaglandin production in the HD-UNCL
kidney. Extension of our in vitro results to the in vivo situation
must be made with caution, however. Local factors, such as
blood flow, activity of the renin-angiotensin system, oxygen
tension, and compartmentalization of prostaglandin release
between the intravascular and interstitial spaces could greatly
affect prostaglandin production and local tissue concentrations
in the intact kidney. In vivo studies are therefore necessary to
confirm these results.
In the non-diabetic clipped kidney, reduced glomerular cap-
illary pressures and flows are present, and hyperfiltration does
not occur [20]. Nevertheless, upon the superimposition of
diabetes mellitus, clipped kidneys hypertrophy and develop
some diabetic glomerular injury [21]. The failure of vasodilator
prostaglandin production to increase in this setting, despite the
presence of diabetes mellitus, correlates with the relative pro-
tection which clipped kidneys enjoy from diabetic injury in
comparison to normal and unclipped kidneys of experimental
animals [211[.
These data suggest a complex interrelationship between
diabetes mellitus, glomerular prostaglandin metabolism, and
glomerular hemodynamic control. Individually, neither diabe-
tes mellitus or hyperfiltration are necessarily associated with
enhanced glomerular vasodilator prostaglandin production as
illustrated by the findings in HD-CL and H-UNCL kidneys,
respectively. However, glomerular prostaglandin production is
increased when these conditions coexist, as in HD-UNCL
kidneys. Inasmuch as the present study is correlative in design,
it is not possible to definitively assign a causal relationship
between enhanced prostaglandin production, hyperfiltration,
and diabetic glomerular injury. Taken together with previous
functional studies [11—14], however, results of the present study
are consistent with the concept that prostaglandins may partic-
ipate in the renal hemodynamic disturbances associated with
diabetes mellitus. Although hyperfiltration and enhanced gb-
merular prostaglandin production are most prominent in the
early phases of experimental diabetes, significant glomerular
injury occurs over a period of months [211. Recently, Jensen et
al [34] showed that vasodilator prostaglandins continue to exert
an important hemodynamic effect later in the course of exper-
imental diabetes, when hyperfiltration is less prominent.
Unlike the renal glomerulus, extrarenal vascular 6-keto PGF1,
production may be reduced in diabetes mellitus [35,36]. There-
fore, aortic 6-keto PGF1a production was evaluated to assess
the effects of superimposed hypertension and diabetes mellitus
on vascular prostaglandin production outside the kidney. In this
tissue, combined hypertension and diabetes mellitus produced
the same small, statistically insignificant fall in 6-keto PGF1a
production as isolated diabetes mellitus.
In summary, glomerular prostaglandin metabolism was eval-
uated in a model of simultaneous diabetes mellitus and reno-
vascular hypertension in which the two kidneys have differing
hemodynarnic environments and susceptibilities to diabetic
glomerular injury. Despite exposure to a similar diabetic envi-
ronment, glomerular vasodilator prostaglandin production dif-
fered in the two kidneys, and correlated with their susceptibility
to diabetic glomerular injury. These results suggest that hemo-
dynamic as well as metabolic factors may influence glomerular
prostaglandin metabolism in diabetes mellitus.
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